X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs LUPIN LTD - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD LUPIN LTD WYETH LTD/
LUPIN LTD
 
P/E (TTM) x 27.7 16.6 167.2% View Chart
P/BV x 5.3 3.9 138.5% View Chart
Dividend Yield % 1.3 0.8 159.8%  

Financials

 WYETH LTD   LUPIN LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
LUPIN LTD
Mar-16
WYETH LTD/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,0442,127 49.1%   
Low Rs8181,294 63.2%   
Sales per share (Unadj.) Rs298.6304.1 98.2%  
Earnings per share (Unadj.) Rs57.250.4 113.6%  
Cash flow per share (Unadj.) Rs58.460.7 96.3%  
Dividends per share (Unadj.) Rs17.007.50 226.7%  
Dividend yield (eoy) %1.80.4 416.4%  
Book value per share (Unadj.) Rs249.5243.8 102.3%  
Shares outstanding (eoy) m22.72450.58 5.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.15.6 55.4%   
Avg P/E ratio x16.333.9 47.9%  
P/CF ratio (eoy) x15.928.2 56.6%  
Price / Book Value ratio x3.77.0 53.2%  
Dividend payout %29.714.9 199.6%   
Avg Mkt Cap Rs m21,157770,740 2.7%   
No. of employees `0000.516.4 3.0%   
Total wages/salary Rs m40021,077 1.9%   
Avg. sales/employee Rs Th13,787.48,379.6 164.5%   
Avg. wages/employee Rs Th813.01,289.0 63.1%   
Avg. net profit/employee Rs Th2,643.31,388.7 190.3%   
INCOME DATA
Net Sales Rs m6,783137,016 5.0%  
Other income Rs m3531,877 18.8%   
Total revenues Rs m7,136138,893 5.1%   
Gross profit Rs m1,61737,535 4.3%  
Depreciation Rs m274,635 0.6%   
Interest Rs m6446 1.2%   
Profit before tax Rs m1,93834,330 5.6%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m63211,536 5.5%   
Profit after tax Rs m1,30122,707 5.7%  
Gross profit margin %23.827.4 87.0%  
Effective tax rate %32.633.6 97.1%   
Net profit margin %19.216.6 115.7%  
BALANCE SHEET DATA
Current assets Rs m6,98497,790 7.1%   
Current liabilities Rs m2,05653,872 3.8%   
Net working cap to sales %72.632.1 226.6%  
Current ratio x3.41.8 187.1%  
Inventory Days Days9985 117.2%  
Debtors Days Days24121 19.8%  
Net fixed assets Rs m24486,379 0.3%   
Share capital Rs m227901 25.2%   
"Free" reserves Rs m5,441105,735 5.1%   
Net worth Rs m5,668109,844 5.2%   
Long term debt Rs m2553,739 0.0%   
Total assets Rs m7,901224,378 3.5%  
Interest coverage x353.377.9 453.3%   
Debt to equity ratio x00.5 0.9%  
Sales to assets ratio x0.90.6 140.6%   
Return on assets %16.510.3 160.2%  
Return on equity %22.920.7 111.0%  
Return on capital %34.021.2 160.5%  
Exports to sales %0.249.1 0.4%   
Imports to sales %36.37.4 488.2%   
Exports (fob) Rs m1567,244 0.0%   
Imports (cif) Rs m2,46510,199 24.2%   
Fx inflow Rs m1571,405 0.0%   
Fx outflow Rs m2,67717,807 15.0%   
Net fx Rs m-2,66253,598 -5.0%   
CASH FLOW
From Operations Rs m923-3,690 -25.0%  
From Investments Rs m317-69,434 -0.5%  
From Financial Activity Rs m-48158,126 -0.8%  
Net Cashflow Rs m759-14,998 -5.1%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 51.1 0.2 25,550.0%  
Indian inst/Mut Fund % 11.3 11.3 100.0%  
FIIs % 7.2 31.9 22.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 10.1 301.0%  
Shareholders   21,978 98,259 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  SHASUN PHARMA  SANOFI INDIA  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - CIPLA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS